Accessibility Menu
Alibaba Health Information Technology logo

Alibaba Health Information Technology(OTC) ALBBY

Market Cap$7.14BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-50%
5 Year-73%
1 Year-29%
1 Month+5%
$8.88
+0.00%
+0.00Today
Alibaba Health Information Technology last closing stock price
MetricPriceDate
Last closeUSD 8.282026-08-13
Alibaba Health Information Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 8.282026-08-06
1 month+5.29%USD 7.862026-07-14
3 month-20.7%USD 10.442026-05-15
Year to date-32.65%USD 12.292025-12-31
1 year-29.2%USD 11.692025-08-07
3 year-35.87%USD 12.902023-08-14
5 year-73.42%USD 31.142021-08-12
Since inception-49.57%USD 16.622019-09-30

Alibaba Health Information Technology Financials at a Glance

Market Cap

$7.14BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥58.25B

Net Income (TTM)

CN¥2.91B

EPS (TTM)

$0.34

P/E Ratio

26.27

Dividend

$0.18

Beta (Volatility)

0.48 (Low)

Price

$8.88

Volume

159

Open

$8.88

Previous Close

$8.28

Daily Range

$8.88 - $8.88

52-Week Range

$7.48 - $18.57

Estimated Earnings Date

May 18, 2026

ALBBY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alibaba Health Information Technology

Alibaba Health Information Technology Limited is a leading player in the healthcare technology sector, focusing on pharmaceutical retail and digital healthcare services. The company operates a comprehensive e-commerce platform for health-related products, catering to both individual consumers and businesses across Mainland China and Hong Kong.

Products and Services
  • Extensive e-commerce platform for health products, including medications and medical devices
  • Digital healthcare services such as online consultations and health checkups
  • Supply chain tracking and internet hospital services
Growth Outlook
  • Revenue increased to CNY 17.24 billion in Q4 2026, reflecting strong demand
  • Net income rose to CNY 657 million in Q4 2026, showcasing profitability
  • TTM gross profit margin stands at 23.97%, indicating operational efficiency
Financial Highlights
  • Current ratio of 3.03, demonstrating strong liquidity position
  • Return on equity at 10.95%, reflecting effective management of shareholder funds
  • Net cash provided by operating activities reached CNY 796 million in Q4 2026
Alibaba Health Information Technology Limited has established itself as a significant entity in the healthcare sector, leveraging technology to enhance service delivery and product accessibility. The company's diverse offerings, including both B2C and B2B services, position it well for future growth. Recent financial performance indicates a robust operational framework, with increasing revenues and profitability. The strong liquidity and return on equity further underscore the company's financial health, making it an intriguing option for potential investors interested in the healthcare technology landscape.
AI Generated • Aug 11, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

1,394

CEO

Di Fan Shen

Website

www.alihealth.cn

Headquarters

Hong Kong, HK

ALBBY Financials

Key Financial Metrics (TTM)

Gross Margin

23.97%

Operating Margin

5.36%

Net Income Margin

5.65%

Return on Equity

10.95%

Return on Capital

9.96%

Return on Assets

8.41%

Earnings Yield

3.81%

Dividend Yield

1.98%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.14BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

806.32M

Volume

159

Avg. Volume

524.016

Financials (TTM)

Gross Profit

CN¥13.93B

Operating Income

CN¥2.85B

EBITDA

CN¥3.24B

Operating Cash Flow

CN¥2.69B

Capital Expenditure

-CN¥14.19M

Free Cash Flow

CN¥2.67B

Cash & ST Invst.

CN¥10.45B

Total Debt

CN¥59.53M

Alibaba Health Information Technology Performance Analysis

Alibaba Health Information Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CNY 3,904,654,03821.8%
20242024-03-31CNY 3,771,127,924-3.4%
20252025-03-31CNY 4,238,955,84012.4%
20262026-03-31CNY 4,822,658,27713.8%
Alibaba Health Information Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-12-31-42.8%
Q42025-03-31100.0%
Q22025-09-30N/A
Q42026-03-31N/A
Alibaba Health Information Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CNY 0.12N/A
20242024-03-31CNY 0.1851.6%
20252025-03-31CNY 0.2540.6%
20262026-03-31CNY 0.3436.8%
Alibaba Health Information Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-12-31-57.1%
Q42025-03-31100.0%
Q22025-09-30N/A
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CN¥17.24B

+20.8%

Gross Profit

CN¥3.95B

+11.9%

Gross Margin

22.93%

N/A

Market Cap

$7.14BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.12M

N/A

Employees

1,394

N/A

Net Income

CN¥657.47M

-14.5%

EBITDA

CN¥732.33M

-6.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CN¥10.45B

+35.1%

Total Debt

CN¥59.53M

-12.5%

Accounts Receivable

CN¥1.26B

-44.9%

Inventory

CN¥1.84B

+12.7%

Long Term Debt

CN¥30.06M

-25.9%

Short Term Debt

CN¥29.47M

+7.3%

Return on Assets

8.41%

N/A

Return on Invested Capital

10.24%

N/A

Free Cash Flow

CN¥679.19M

+21.5%

Operating Cash Flow

CN¥673.16M

+19.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHEOYCochlear Limited
$46.89-0.13%
CHEOFCochlear Limited
$93.00+11.51%
BMXMFbioMérieux S.A.
$82.66+4.65%
CHJTFCSPC Pharmaceutical Group Limited
$1.07+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.36+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.61-0.00%
INTCIntel
$102.95-0.02%
ONDSOndas
$9.47+0.06%

Questions About ALBBY

What is the current price of Alibaba Health Information Technology?

Alibaba Health Information Technology is trading at $8.88 per share.

What is the 52-week range for Alibaba Health Information Technology?

Over the past 52 weeks, Alibaba Health Information Technology has traded between $7.48 and $18.57.

How much debt does Alibaba Health Information Technology have?

As of the most recent reporting period, Alibaba Health Information Technology reported total debt of CN¥8.65M.

How much cash does Alibaba Health Information Technology have on hand?

Alibaba Health Information Technology reported CN¥832.76M in cash and cash equivalents in its most recent financial results.

What is Alibaba Health Information Technology’s dividend yield?

Alibaba Health Information Technology currently has a dividend yield of 1.98%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services